LD-2 disclosure · 2nd Quarter - Termination
LYKOS THERAPEUTICS
Client
- Description
- Healthcare/pharmaceuticals
- Location
- California · United States of America
Registrant
- Location
- San Jose, California, United States of America
Lobbying activities
4 issuesBudget/Appropriations
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).
LobbyistsKACY HUTCHISON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Defense
Issues related to MDMA Assisted Therapy research, education and capacity building to support treating mental health challenges, including PTSD (no bill); issues related to therapeutics and implementation research and development (Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, H.R. 3944 / no Senate bill number).
LobbyistsKACY HUTCHISON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Issues related to pharmaceutical distribution (SUPPORT for Patients and Communities Reauthorization Act of 2025, H.R. 2483 / S. 2121).
LobbyistsKACY HUTCHISON